Hermes J. Garban

5 Patents

• US124126392025

  Method of Characterizing a Tumor Based on an Immune Gene Expression Signature in Regulatory T Cell (treg)-enriched Tumor Samples

  Nant Holdings IP, LLC

  0 cites
• US120982012024

  Anti-tim3 Monoclonal Antibodies and Chimeric Antigen Receptors

  Nantbio, Inc.

  0 cites
• US118144362023

  0 cites
• US117534672023

  Anti-tim3 Monoclonal Antibodies and Chimeric Antigen Receptors

  Nantbio, Inc.

  0 cites
• US117566512023

  Method of Treating a Tumor in a Patient Based on an Immune Gene Expression

  Nant Holdings IP, LLC

  0 cites